UTI Dual Advantage Fixed Term Fund Series III-II - Growth - Regular Plan

  • Previous Nav

  • Net Change on 07-01-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the Scheme is to generate income and reduce interest rate volatility by investing in fixed income securities that are maturing on or before the date of maturity of the Scheme and generate capital appreciation by investing in equity and equity related instruments. However there is no assurance that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
CRISIL Hybrid 85+15 - Conservative Index 0.54 2.35 11.31 8.00 8.46 8.82

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Fund Holdings as on 31-December-2019

  • NET CURRENT ASSETS

  • MF UNITS-UTI LIQUID CASH PLAN -DIRECT GROWTH

  • DDB HERO FINCORP LTD.

  • NCD L & T INFRASTRUCTURE FINANCE COMPANY LIMITED

  • EQ ICICI BANK LTD

  • EQ INFOSYS LTD.

  • EQ MPHASIS LTD

  • EQ SUN PHARMACEUTICALS INDUSTRIES LTD.

  • EQ GAIL (INDIA) LTD.

  • EQ MRF LTD.

  • EQ TATA GLOBAL BEVERAGES LTD.

  • EQ MAHINDRA & MAHINDRA LTD.

  • EQ PROCTER & GAMBLE HYGIENE & HEL CARE LTD.

  • EQ HCL TECHNOLOGIES LTD.

  • EQ NTPC LTD.

  • EQ ORACLE FINANCIAL SERVICES SOFTWARE LTD.

  • EQ EXIDE INDUSTRIES LTD.

  • EQ SUN TV NETWORK LTD.

  • EQ GHCL LTD.

  • EQ AUROBINDO PHARMA LTD.

  • EQ CADILA HEALTHCARE LTD.

View More
  • Miscellaneous

  • IT - Software

  • Bank - Private

  • Pharmaceuticals & Drugs

  • Industrial Gases & Fuels

  • Tyres & Allied

  • Tea/Coffee

  • Automobiles - Passenger Cars

  • Household & Personal Products

  • Power Generation/Distribution

  • Batteries

  • TV Broadcasting & Software Production

  • Chemicals

View More

About UTI Dual Advantage Fixed Term Fund Series III-II

Scheme Analysis

UTI Dual Advantage Fixed Term Fund Series III-II is a Hybrid - Balanced Hybrid Fund fund and belongs to UTI Mutual Fund. It was launched on 08-Jul-2016 and currently has an AUM of ₹64.79 crore. UTI Dual Advantage Fixed Term Fund Series III-II is benchmarked against CRISIL Hybrid 85+15 - Conservative Index as primary index.

The NAV of UTI Dual Advantage Fixed Term Fund Series III-II ended up ₹0(0.01%)yesterday to ₹11.3887.

Among its top 3 holdings the fund has exposure to NET CURRENT ASSETS, and

The UTI Dual Advantage Fixed Term Fund Series III-II is managed by V. Srivatsa and Sunil Patil.

Fund House Contact

UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 66786666
service@uti.co.in
+91 (22) 66786503,56786578
www.utimf.com

Fund Manager

  • CARE-AAA

  • Cash

  • Equity

  • ICRA-AA+

  • MFU

View More